The "Trending Topics at Sessions 2022" panel of experts featured Manesh R. Patel, MD, FACC, FAHA, Chair of the Committee on AHA 2022 Scientific Sessions, to review highlights and lessons learned from the event.
November 14, 2022
AHA 2022 Trending Topics: Clinical Trials, Scientific Studies and AI
November 14, 2022 — The American Hospital Association Scientific Sessions 2022, held Nov. 5-7 in Chicago, IL, presented…
Read More
Investigators Compared AFib Patients Treated with Catheter Ablation to Those Treated with Anti-arrhythmic Drugs Only
November 10, 2022
Study Finds Catheter Ablation Significantly Lowers Risk of Dementia in Patients with Atrial Fibrillation
November 10, 2022 —  Biosense Webster, Inc., the global leader in cardiac arrhythmia treatment and part of Johnson…
Read More
Cryoablation involves guiding a small tube into the heart and inflating a small balloon to kill problematic tissue with cold temperatures. Image courtesy of Medtronic
November 10, 2022
National Study Suggests It's Time to Rethink How We Treat Atrial Fibrillation
November 10, 2022 —  A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding…
Read More
When the SARS-CoV-2 protein Nsp6 is made in a fruit fly heart (center), the heart has structural defects compared to a normal heart without the viral protein (left). When fruit fly hearts with the viral Nsp6 protein are given the metabolism changing drug 2DG (right), the hearts begin to look more normal than the ones with the viral protein that do not have the drug. Image courtesy of Zhe Han at UMSOM
November 10, 2022
How a SARS-CoV-2 Virus Protein Damages the Heart
November 10, 2022 —  Researchers at the University of Maryland School of Medicine’s (UMSOM) Center for Precision…
Read More
Findings from the BEST-CLI trial presented at the American Heart Association Scientific Sessions (AHA2022) indicate optimal treatment for patients with limb-threatening ischemia.  
November 10, 2022
BEST-CLI Clinical Trial Focuses on Optimal Treatment for Limb-Threatening Ischemia
November 10, 2022 ­– Significant findings from the clinical trial, known as “BEST-CLI — Best Endovascular versus Best…
Read More
80-year-old patient with nonischemic dilated cardiomyopathy. Ejection fraction was 25.2%. Patient underwent cardiac MRI. A. Radial strain overlay on short-axis cine image and corresponding graph show global radial strain measurement, yielding value of 10.8%. B. Circumferential strain overlay on short-axis cine image and graph show global circumscribed strain measurement, yielding value of -8.5%. C. Longitudinal strain overlay on 4-chamber cine image and graph show global longitudinal strain measurement, yie
November 09, 2022
Myocardial Strain Parameters on MRI in Patients With Dilated Cardiomyopathy
November 9, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), left…
Read More
Risk Reductions of 46% to 52% for Heart Failure Readmissions and for Composite of CV Death and Heart Failure Readmissions at 30- and 90-Days Following Hospital Discharge
November 09, 2022
New Analysis of SOLOIST-WHF Results Demonstrates Sotagliflozin’s Significant Effect in Reducing the Risk of Hospital Readmissions for Heart Failure
November 9, 2022 —  Lexicon Pharmaceuticals, Inc. announced that a new analysis of results from the SOLOIST-WHF Phase 3…
Read More
Risk Reductions of 46% to 52% for Heart Failure Readmissions and for Composite of CV Death and Heart Failure Readmissions at 30- and 90-Days Following Hospital Discharge
November 09, 2022
CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions
November 9, 2022 — CinCor Pharma, Inc. announced the presentation today of Phase 2 data from its BrigHtn trial as part…
Read More
By Bhvita Jani
November 09, 2022
Interventional X-ray and Mobile C-arm Equipment Markets Had a Double-digit Recovery in 2021
The world market for interventional X-ray and mobile C-arm equipment is forecast to reach over $4.9 billion by 2026,…
Read More
November 09, 2022
American Heart Association Honors Distinguished Scientists at AHA22
November 9, 2022 — Seven awardees were honored during the American Heart Association Scientific Sessions (AHA 2022).…
Read More
Tech tools are creating positive change in Cardiac MRI Software Market
By Christine Book
November 09, 2022
AI-powered Software Solutions Enhance Cardiac Diagnostics
Interventional cardiologists know well the phrase “change is the only constant.” This is especially relevant as…
Read More
Artificial intelligence-powered alternative data is driving novel and disruptive market research opportunities at a staggering clip amid category growth forecasts, prompting industries of every size and sort to capitalize on this strategy that’s ever evolving and innovating 
By Merilee Kern, MBA
November 09, 2022
AI-Powered Alternative Data Driving Extreme Market Research Disruption
Numerous indicators make clear that the next five years will usher in extreme transformation for a multitude of…
Read More
New genomic therapies for cardiovascular disease are reaching the clinical trial stage, according to moderators of a session presented at the American Heart Association Annual Scientific Session (AHA2022).
November 08, 2022
Progress Reported on Clinical Trials of Genomic Profiling for Cardiovascular Disease at AHA 2022
November 8, 2022 — Genomic-based therapies for cardiovascular disease are emerging fast in research, and could soon be…
Read More
Robert J. Mentz, M.D., Associate Professor of Medicine, Chief, Heart Failure Section, Associate Program Director, Duke Cardiology Fellowship, Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, image copyright Robert J. Mentz
November 08, 2022
TRANSFORM-HF Trial Found No Difference in Effectiveness Between 2 Common Loop Diuretics
November 8, 2022 — After hospital discharge for heart failure, people treated with either loop diuretic medication…
Read More
Julian D. Gillmore, M.D., Ph.D., Professor, University College London Centre for Amyloidosis, United Kingdom, image copyright University College London Centre for Amyloidosis
November 08, 2022
Novel Gene-Editing Therapy Shows Promise For Patients With Transthyretin Amyloid Cardiomyopathy
November 8, 2022 — A single IV infusion of NTLA-2001, a novel CRISPR/Cas9-based gene editing therapy, significantly…
Read More
Clinical studies presented at the American Heart Association 2022 Scientific Sessions event demonstrate compelling diagnostic and health economic value of the Zio suite of products across a range of clinical applications
November 08, 2022
Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22
November 8, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions…
Read More
Cardio StillShot enables 6x higher temporal resolution compared to conventional image reconstruction methods by detecting and correcting motion in the heart
November 08, 2022
Fujifilm Introduces Scenaria View Focus Edition CT Scanner with Cardio StillShot, a new Cardiac Motion Correction Feature
November 8, 2022 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging…
Read More
Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more accurate non-invasive diagnosis, fewer unnecessary tests, and higher confidence in identifying patients needing treatment
November 07, 2022
Late-Breaking Data Demonstrate AHA/ACC Guideline-Directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing
November 7, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heartcare, today announced new trial…
Read More
A new analysis of iRhythm’s mSToPS trial, presented at the American Heart Association, reveals that Zio XT provided high value from a health economic perspective
November 07, 2022
New Research Confirms that Zio by iRhythm Provides High Value From a Health Economic Perspective
November 7, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions…
Read More
Petr Ostadal, M.D., Ph.D., Professor of Medicine, Department of Cardiology, Na Homolce Hospital, Czech Republic. Image copyright Na Homolce Hospital
November 07, 2022
Early Use of ECMO devices Did Not Improve Outcomes in People With Cardiogenic Shock
November 7, 2022 — The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now